FindTrial
Sign In

Efficacy comparison and long-term follow-up of ATG-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anemia: a single-center cohort study

Efficacy comparison and long-term follow-up of ATG-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anemia: a single-center cohort study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065804
Enrollment
Unknown
Registered
2022-11-15
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aplastic anemia

Interventions

IST group:N/A
HSCT group:N/A

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria of TD-NSAA; Aged 16-60 years.

Exclusion criteria

Exclusion criteria: Complicated with severe cardiovascular and cerebrovascular, liver, kidney and immune system diseases; pregnant or lactating women; patients who refuse to follow up.

Design outcomes

Primary

MeasureTime frame
blood routine;efficacy;treatment outcome;safety;Graft-versus-host disease;serum ferritin;—

Countries

China

Contacts

Public ContactWu Dijiong

Zhejiang Provincial Hospital of Traditional Chinese Medicine

wdj850@163.com+86 13989463963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026